Chemotoxicity and Cellular Protection Research Some preclinical studies suggest FOXO4-DRI may help reduce tissue damage associated with certain chemotherapy compounds, including doxorubicin
Copper in excess is genuinely toxic, and in a zebrafish model free copper caused heart toxicity (Hsiao et al., 2020) though in that same study the GHK peptide chelated copper and reduced the harm, so GHK-Cu is not equivalent to free copper
While this study was not a head-to-head clinical trial comparison, it may be relevant that at week 12 of a weekly dosing regimen, some studies suggest that participants treated with semaglutide (Wegovy, Novo Nordisk) had an approximately 6% decrease from baseline in body weight, whereas those treated with tirzepatide (Zepbound, Eli Lilly) had an approximately 8% decrease from baseline in body weight at the same time period, Bays said
Gender Differences in the Context of Obstructive Sleep Apnea and Metabolic Diseases Allen, J., & Bradley, R.D
& Fu, J
